Sofinnova Investments, Inc. Dexcom Inc Transaction History

Sofinnova Investments, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$110.31 - $140.45 $6.78 Million - $8.64 Million	61,494 New	61,494 $6.97 Million
Q4 2023 Aug 15, 2024	SELL	$75.49 - $124.16 $3.13 Million - $5.15 Million	-41,494 Reduced 67.48%	20,000 $2.48 Million
Q4 2023 Feb 12, 2024	SELL	$75.49 - $124.16 $26.5 Million - $43.5 Million	-350,720 Reduced 94.61%	20,000 $2.48 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $12.8 Million - $14.9 Million	113,493 Added 44.12%	370,720 $47.6 Million
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $12.1 Million - $14.3 Million	116,549 Added 82.85%	257,227 $29.9 Million
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $5.55 Million - $8.01 Million	-65,270 Reduced 31.69%	140,678 $15.9 Million
Q3 2022 Nov 08, 2022	BUY	$76.35 - $94.18 $1.29 Million - $1.59 Million	16,856 Added 8.91%	205,948 $16.6 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $10.1 Million - $19.8 Million	148,827 Added 369.62%	189,092 $14.1 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $739,562 - $1.02 Million	7,861 Added 24.26%	40,265 $20.6 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $631,427 - $791,630	-4,862 Reduced 13.05%	32,404 $17.4 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $379,140 - $508,718	3,553 Added 10.54%	37,266 $20.4 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $543,685 - $724,534	6,713 Added 24.86%	33,713 $14.4 Million
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $2.29 Million - $2.83 Million	27,000 New	27,000 $9.7 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.